Quarterly report · Q3

Period2021-12-01 → 2022-08-31

Filed2022-10-11

StandardJapan GAAP

ConsolidatedYes

Data checks12 of 12 passed

Key figures · 33

Metric	Value	Period	Scope	Source row
Revenue	¥6.1bn	2021-12-01 → 2022-08-31	Cons.	Net sales
Revenue	¥7.9bn	2020-12-01 → 2021-11-30	Cons.	Net sales (5-year summary)
Revenue	¥5.8bn	2020-12-01 → 2021-08-31	Cons.	Net sales
Operating income	¥331m	2021-12-01 → 2022-08-31	Cons.	Operating income
Operating income	¥347m	2020-12-01 → 2021-08-31	Cons.	Operating income
Ordinary income	¥345m	2021-12-01 → 2022-08-31	Cons.	Ordinary income
Ordinary income	¥386m	2020-12-01 → 2021-11-30	Cons.	Ordinary income loss (5-year summary)
Ordinary income	¥349m	2020-12-01 → 2021-08-31	Cons.	Ordinary income
Profit before tax	¥343m	2021-12-01 → 2022-08-31	Cons.	Income before income taxes
Profit before tax	¥357m	2020-12-01 → 2021-08-31	Cons.	Income before income taxes
Net income (owners)	¥266m	2021-12-01 → 2022-08-31	Cons.	Profit loss attributable to owners of parent
Net income (owners)	¥281m	2020-12-01 → 2021-11-30	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income (owners)	¥259m	2020-12-01 → 2021-08-31	Cons.	Profit loss attributable to owners of parent
Net income	¥266m	2021-12-01 → 2022-08-31	Cons.	Profit loss
Net income	¥259m	2020-12-01 → 2021-08-31	Cons.	Profit loss
Total assets	¥8.3bn	at 2022-08-31	Cons.	Assets
Total assets	¥7.9bn	at 2021-11-30	Cons.	Assets
Total assets	¥7.7bn	at 2021-08-31	Cons.	Total assets (5-year summary)
Total liabilities	¥5.9bn	at 2022-08-31	Cons.	Liabilities
Total liabilities	¥5.6bn	at 2021-11-30	Cons.	Liabilities
Net assets / equity	¥2.5bn	at 2022-08-31	Cons.	Net assets
Net assets / equity	¥2.3bn	at 2021-11-30	Cons.	Net assets
Net assets / equity	¥2.2bn	at 2021-08-31	Cons.	Net assets (5-year summary)
Cash and deposits	¥1.1bn	at 2022-08-31	Cons.	Cash and deposits
Cash and deposits	¥1.3bn	at 2021-11-30	Cons.	Cash and deposits
EPS (basic)	¥218.07	2021-12-01 → 2022-08-31	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥71.01	2022-06-01 → 2022-08-31^d	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥230.99	2020-12-01 → 2021-11-30	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥213.08	2020-12-01 → 2021-08-31	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥52.78	2021-06-01 → 2021-08-31^d	Cons.	Basic earnings loss per share (5-year summary)
Equity ratio	29.6%	at 2022-08-31	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	28.5%	at 2021-11-30	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	28.8%	at 2021-08-31	Cons.	Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. ^d = earlier-year period dated by calendar; ^v = that date confirmed by the company's own earlier filing.

Segments · 18

Segment	Item	Period	Value
jpcrp040300-q3r_E01006-000Pharmaceutical Productsreportable segment	revenue	2021-12-01 → 2022-08-31	¥6.1bn
jpcrp040300-q3r_E01006-000Pharmaceutical Productsreportable segment	revenue external	2021-12-01 → 2022-08-31	¥6.1bn
jpcrp040300-q3r_E01006-000Pharmaceutical Productsreportable segment	segment profit	2021-12-01 → 2022-08-31	¥308m
jpcrp040300-q3r_E01006-000Real Estate Leasingreportable segment	revenue	2021-12-01 → 2022-08-31	¥29m
jpcrp040300-q3r_E01006-000Real Estate Leasingreportable segment	revenue external	2021-12-01 → 2022-08-31	¥29m
jpcrp040300-q3r_E01006-000Real Estate Leasingreportable segment	segment profit	2021-12-01 → 2022-08-31	¥23m
Total Of Reportable Segments And Otherssegment total	revenue	2021-12-01 → 2022-08-31	¥6.1bn
Total Of Reportable Segments And Otherssegment total	revenue external	2021-12-01 → 2022-08-31	¥6.1bn
Total Of Reportable Segments And Otherssegment total	segment profit	2021-12-01 → 2022-08-31	¥331m
jpcrp040300-q3r_E01006-000Pharmaceutical Productsreportable segment	revenue	2020-12-01 → 2021-08-31	¥5.7bn
jpcrp040300-q3r_E01006-000Pharmaceutical Productsreportable segment	revenue external	2020-12-01 → 2021-08-31	¥5.7bn
jpcrp040300-q3r_E01006-000Pharmaceutical Productsreportable segment	segment profit	2020-12-01 → 2021-08-31	¥324m
jpcrp040300-q3r_E01006-000Real Estate Leasingreportable segment	revenue	2020-12-01 → 2021-08-31	¥28m
jpcrp040300-q3r_E01006-000Real Estate Leasingreportable segment	revenue external	2020-12-01 → 2021-08-31	¥28m
jpcrp040300-q3r_E01006-000Real Estate Leasingreportable segment	segment profit	2020-12-01 → 2021-08-31	¥23m
Total Of Reportable Segments And Otherssegment total	revenue	2020-12-01 → 2021-08-31	¥5.8bn
Total Of Reportable Segments And Otherssegment total	revenue external	2020-12-01 → 2021-08-31	¥5.8bn
Total Of Reportable Segments And Otherssegment total	segment profit	2020-12-01 → 2021-08-31	¥347m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 352

Item	Context	Value	Unit
Other information consolidated financial statements etc (text)	CurrentYTDDuration	Text · Plus
Information about company which provides guarantee to reporting company (text)	FilingDateInstant	Text · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed

balance sheet identity	consolidated 2021-11-30	pass
balance sheet identity	consolidated 2022-08-31	pass rounding
dei present		pass
period resolution		pass
statement vs summary · net assets	consolidated 2021-11-30	pass
statement vs summary · net assets	consolidated 2022-08-31	pass
statement vs summary · net income attributable to parent	consolidated 2020-12-01/2021-08-31	pass
statement vs summary · net income attributable to parent	consolidated 2021-12-01/2022-08-31	pass
statement vs summary · revenue	consolidated 2020-12-01/2021-08-31	pass
statement vs summary · revenue	consolidated 2021-12-01/2022-08-31	pass
statement vs summary · total assets	consolidated 2021-11-30	pass
statement vs summary · total assets	consolidated 2022-08-31	pass